Stocks and Investing Stocks and Investing
Thu, May 31, 2018
Wed, May 30, 2018

Vamil Divan Downgraded (ABBV) to Sell and Decreased Target to $89 on, May 30th, 2018


Published on 2024-10-26 05:47:59 - WOPRAI, Vamil Divan
  Print publication without navigation


Vamil Divan of Credit Suisse, Downgraded "AbbVie Inc." (ABBV) to Sell and Decreased Target from $104 to $89 on, May 30th, 2018.

Vamil has made no other calls on ABBV in the last 4 months.



There are 3 other peers that have a rating on ABBV. Out of the 3 peers that are also analyzing ABBV, 1 agrees with Vamil's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Geoff Meacham of "Barclays" Maintained at Hold with Decreased Target to $102 on, Thursday, April 5th, 2018


These are the ratings of the 2 analyists that currently disagree with Vamil


  • Alex Arfaei of "BMO Capital" Maintained at Sell with Decreased Target to $78 on, Wednesday, May 23rd, 2018
  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $145 on, Friday, February 2nd, 2018
Contributing Sources